Uscom Ltd (UCM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Uscom Ltd (UCM) has a cash flow conversion efficiency ratio of -7.065x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.29 Million ≈ $-913.86K USD) by net assets (AU$182.80K ≈ $129.34K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Uscom Ltd (UCM) defensive interval to measure how many days the company can operate on defensive assets alone.
Uscom Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Uscom Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Uscom Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Uscom Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vp plc
LSE:VP
|
0.245x |
|
Crest Nicholson Holdings plc
LSE:CRST
|
0.080x |
|
Magle Chemoswed Holding Ab
ST:MAGLE
|
-0.006x |
|
UIL Ltd
LSE:UTL
|
0.057x |
|
Grand Gulf Energy Ltd
AU:GGE
|
-0.003x |
|
Global Health Ltd
AU:GLH
|
0.017x |
|
Chesterfield Resources PLC
LSE:CHF
|
-0.295x |
|
CCSC Technology International Holdings Limited Ordinary Shares
NASDAQ:CCTG
|
-0.041x |
Annual Cash Flow Conversion Efficiency for Uscom Ltd (2005–2025)
The table below shows the annual cash flow conversion efficiency of Uscom Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Uscom Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$-38.22K ≈ $-27.05K |
AU$-2.71 Million ≈ $-1.92 Million |
70.897x | +18753.99% |
| 2024-06-30 | AU$3.06 Million ≈ $2.17 Million |
AU$-1.16 Million ≈ $-823.17K |
-0.380x | +18.76% |
| 2023-06-30 | AU$3.04 Million ≈ $2.15 Million |
AU$-1.42 Million ≈ $-1.01 Million |
-0.468x | -186.98% |
| 2022-06-30 | AU$5.94 Million ≈ $4.20 Million |
AU$-967.51K ≈ $-684.58K |
-0.163x | -1012.52% |
| 2021-06-30 | AU$3.08 Million ≈ $2.18 Million |
AU$54.98K ≈ $38.90K |
0.018x | +121.59% |
| 2020-06-30 | AU$3.42 Million ≈ $2.42 Million |
AU$-283.23K ≈ $-200.40K |
-0.083x | +76.33% |
| 2019-06-30 | AU$3.49 Million ≈ $2.47 Million |
AU$-1.22 Million ≈ $-862.86K |
-0.350x | +0.16% |
| 2018-06-30 | AU$4.84 Million ≈ $3.43 Million |
AU$-1.70 Million ≈ $-1.20 Million |
-0.350x | -38.97% |
| 2017-06-30 | AU$3.78 Million ≈ $2.67 Million |
AU$-952.04K ≈ $-673.63K |
-0.252x | +3.60% |
| 2016-06-30 | AU$4.94 Million ≈ $3.49 Million |
AU$-1.29 Million ≈ $-913.32K |
-0.261x | +39.74% |
| 2015-06-30 | AU$2.29 Million ≈ $1.62 Million |
AU$-992.80K ≈ $-702.47K |
-0.434x | -16.52% |
| 2014-06-30 | AU$3.32 Million ≈ $2.35 Million |
AU$-1.24 Million ≈ $-874.36K |
-0.372x | +9.78% |
| 2013-06-30 | AU$2.35 Million ≈ $1.67 Million |
AU$-971.58K ≈ $-687.45K |
-0.413x | +63.38% |
| 2012-06-30 | AU$1.47 Million ≈ $1.04 Million |
AU$-1.66 Million ≈ $-1.17 Million |
-1.127x | -60.99% |
| 2011-06-30 | AU$3.14 Million ≈ $2.22 Million |
AU$-2.19 Million ≈ $-1.55 Million |
-0.700x | -14.47% |
| 2010-06-30 | AU$2.45 Million ≈ $1.73 Million |
AU$-1.50 Million ≈ $-1.06 Million |
-0.611x | -83.86% |
| 2009-06-30 | AU$3.06 Million ≈ $2.16 Million |
AU$-1.02 Million ≈ $-719.05K |
-0.333x | +32.24% |
| 2008-06-30 | AU$3.41 Million ≈ $2.41 Million |
AU$-1.67 Million ≈ $-1.18 Million |
-0.491x | +17.42% |
| 2007-06-30 | AU$5.50 Million ≈ $3.89 Million |
AU$-3.27 Million ≈ $-2.31 Million |
-0.594x | -58.62% |
| 2006-06-30 | AU$8.51 Million ≈ $6.02 Million |
AU$-3.19 Million ≈ $-2.26 Million |
-0.375x | -70.02% |
| 2005-06-30 | AU$11.75 Million ≈ $8.31 Million |
AU$-2.59 Million ≈ $-1.83 Million |
-0.220x | -- |
About Uscom Ltd
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure w… Read more